港股異動 | 奧園健康(3662.HK)大漲逾12% 股價創8個月新高
格隆匯6月7日丨奧園健康(3662.HK)大幅拉昇漲12.26%,報6.32港元創8個月新高價,成交額放大至6101萬港元,總市值45.9億港元。展望2021年,奧園健康生活除了繼續接管母公司中國奧園陸續交付的已售項目之外,已收購的樂生活、寧波宏建和北京博安(2021年1月並表)業績也將產生全年貢獻。山證國際指出,相關因素將驅動公司2021年業績維持高增長。另外,隨着公司將持續深耕大健康產業,大力發展智慧康養、綜合門診、健康住宅等重點業務,預期相關業務將會為公司未來業績帶來貢獻。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.